A detailed history of Assetmark, Inc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 56,360 shares of LNTH stock, worth $6.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
56,360
Holding current value
$6.05 Million
% of portfolio
0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$58.87 - $83.05 $3.32 Million - $4.68 Million
56,360 New
56,360 $4.53 Million
Q4 2023

Feb 09, 2024

BUY
$55.6 - $77.89 $152,288 - $213,340
2,739 Added 42.9%
9,123 $565,000
Q3 2023

Oct 27, 2023

BUY
$60.27 - $90.75 $384,763 - $579,348
6,384 New
6,384 $443,000
Q1 2023

May 05, 2023

SELL
$47.76 - $82.86 $3,152 - $5,468
-66 Reduced 82.5%
14 $1,000
Q3 2022

Nov 01, 2022

BUY
$61.42 - $86.29 $4,913 - $6,903
80 New
80 $6,000
Q1 2018

May 16, 2018

SELL
$14.85 - $24.3 $148 - $243
-10 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$17.4 - $23.4 $174 - $234
10
10 $0

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.38B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.